University: Home | Calendar | Maps

Dean's Office

Long School of Medicine Dean


Francisco González-Scarano, MD

Robert Hromas, M.D., FACP is the Joe R. and Teresa Lozano Long School of Medicine Dean and UT Health San Antonio Vice President for Medical Affairs. Dr. Hromas earned a B.S. in Biology at Wheaton College, Illinois and his medical degree at The University of Texas Medical School at Houston. He did a post-doctoral research fellowship in the regulation of immunoglobulin gene expression and a residency in Internal Medicine at the University of Iowa, followed by a post-doctoral research fellowship in transcriptional regulation of hematopoiesis at the University of Washington. He also was a hematology fellow at the University of Washington and the Fred Hutchinson Cancer Research Center. He is board certified in Internal Medicine with a subspecialty board certification in hematology.


Dr. Hromas previously served as Chair of the Department of Medicine at University of Florida Health, where he was also the Vice President of the University of Florida Physicians Clinical Practice Association and a member of the UF Health Shands Hospital Executive Board. The University of Florida's Department of Medicine has approximately 360 faculty, 210 residents and fellows, more than 600,000 patient encounters per year along with 24,000 annual hospital admissions. He has trained 29 graduate students or fellows, most of whom have entered academic careers, and 21 junior faculty, almost all of whom have obtained tenure, with three obtaining Hematology-Oncology Division Chief positions. He has served on editorial boards of Blood and Stem Cells and has won numerous teaching and patient care awards, including the Indiana University Humanism in Medical Education Award, the Indiana University Board of Trustees Outstanding Teacher Award, and the People Living Through Cancer Caring Award. He has served as Chair of Scientific Affairs for the American Society of Hematology and as their congressional and media representative.


A seasoned investigator, Dr. Hromas has published over 160 scholarly research papers, has for two decades been continuously funded by the National Institutes of Health and has chaired several NIH and American Cancer Society study sections. His laboratory has isolated and characterized several novel DNA repair proteins that play crucial roles in both cancer chemotherapy resistance and in HIV integration. He currently leads a public-private drug development consortium that is creating new drugs and testing them for effectiveness in treating cancers resistant to chemotherapy.


Prior to his work at the University of Florida, Dr. Hromas served as Chief of Hematology-Oncology and Deputy Director of the Cancer Center at the University of New Mexico, assisting that institution in achieving its designation as a National Cancer Institute Cancer Center.  Before that, he was Deputy Director of the Indiana University Cancer Center, also assisting it in obtaining its first NCI designation. Dr. Hromas has been elected to such honorific scientific organizations as the American Society of Clinical Investigation, the Association of Professors of Medicine, the American Clinical and Climatologic Association and the Association of American Physicians.